Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Karin De Visser"'
Autor:
Nienke E van Trommel, Gemma G Kenter, John Haanen, Tanja D de Gruijl, Sanne Samuels, Ekaterina S Jordanova, Ton Schumacher, Joost H van den Berg, Bastiaan Nuijen, Jos Beijnen, Marc van Beurden, Noor Alida Maria Bakker, Jossie Rotman, Henry J MAA Zijlmans, Maartje van Ruiten, Karin De Visser
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Background Usual vulvar intraepithelial neoplasia (uVIN) is a premalignancy caused by persistent infection with high-risk types of human papillomavirus (HPV), mainly type 16. Even though different treatment modalities are available (eg, surgical exci
Externí odkaz:
https://doaj.org/article/c29336b4129f4a6a8b7b92a61e5b1b59
Autor:
Julia Houthuijzen, Karin De Visser
Publikováno v:
Immunity. 55:1336-1339
Fibroblasts strongly impact tumor progression, but whether they prime the pre-metastatic niche is poorly understood. In this issue of Immunity, Gong and Li et al. identify lung-specific immunosuppressive fibroblasts, which are hijacked by breast canc
Autor:
Jukka Westermarck, Goutham Narla, Karin de Visser, Emilia Peuhu, Heikki Joensuu, Rene H. Medema, Krister Wennerberg, Jochen Maurer, Laura L. Elo, Pauliina Kronqvist, Denise C. Connolly, Karolina Pavic, Xi Qiao, Harri Sihto, Sofia Khan, Prson Gautam, Tove J. Grönroos, Femke M. Feringa, Julia P. Vainonen, Anna N. Cvrljevic, Umar Butt, Caroline Farrington, Srikar G. Nagelli, Anni Laine
Basal-like breast cancers (BLBC) are characterized by defects in homologous recombination (HR), deficient mitotic checkpoint, and high-proliferation activity. Here, we discover CIP2A as a candidate driver of BLBC. CIP2A was essential for DNA damage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58953009a86d62cede066667426b4c40
https://doi.org/10.1158/0008-5472.c.6513027
https://doi.org/10.1158/0008-5472.c.6513027
Autor:
Jukka Westermarck, Goutham Narla, Karin de Visser, Emilia Peuhu, Heikki Joensuu, Rene H. Medema, Krister Wennerberg, Jochen Maurer, Laura L. Elo, Pauliina Kronqvist, Denise C. Connolly, Karolina Pavic, Xi Qiao, Harri Sihto, Sofia Khan, Prson Gautam, Tove J. Grönroos, Femke M. Feringa, Julia P. Vainonen, Anna N. Cvrljevic, Umar Butt, Caroline Farrington, Srikar G. Nagelli, Anni Laine
Supplementary Data from CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1885b41a24ffb845f2d6700db7ba978f
https://doi.org/10.1158/0008-5472.22428465
https://doi.org/10.1158/0008-5472.22428465
Autor:
Mathilde Matthea Machteld Almekinders, Edwin Roger Parra, Tapsi Kumar, Karin De Visser, Tycho Bismeijer, Baohua Sun
Publikováno v:
British Journal of Cancer, 127(7), 1201-1213. Nature Publishing Group
Grand Challenge PRECISION consortium 2022, ' Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk ', British Journal of Cancer, vol. 127, no. 7, pp. 1201-1213 . https://doi.org/10.1038/s41416-022-01888-2
Grand Challenge PRECISION consortium 2022, ' Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk ', British Journal of Cancer, vol. 127, no. 7, pp. 1201-1213 . https://doi.org/10.1038/s41416-022-01888-2
Background Ductal carcinoma in situ (DCIS) is treated to prevent subsequent ipsilateral invasive breast cancer (iIBC). However, many DCIS lesions will never become invasive. To prevent overtreatment, we need to distinguish harmless from potentially h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbaf3af1076b54e78662cd1902b1bde6
https://research.vumc.nl/en/publications/9cd9c8eb-4ba5-491a-8815-1aa6b8db618c
https://research.vumc.nl/en/publications/9cd9c8eb-4ba5-491a-8815-1aa6b8db618c
Autor:
Karin De Visser, Claudia Burrello
Publikováno v:
Cancer Immunol Res
Macrophages often abound within tumors, express colony-stimulating factor 1 receptor (CSF1R), and are linked to adverse patient survival. Drugs blocking CSF1R signaling have been used to suppress tumor-promoting macrophage responses; however, their m
Autor:
Karin De Visser, Danique Duits
Publikováno v:
Seminars in Immunology. 57:101546
Neutrophils are multifaceted innate immune cells that play a significant role in the progression of cancer by exerting both pro- and anti-tumorigenic functions. The crosstalk between cancer cells and neutrophils is complex and emerging evidence is po
Autor:
Karin De Visser
Publikováno v:
Seminars in Immunology. 57:101609
Autor:
Karin De Visser, Bas Kreike
Publikováno v:
Cancer Research. 71:1196-1196